The Endocrinology & Diabetes Section - an interactive full-day event encouraging expert discussions for a broad range of clinical case presentations in endocrinology and diabetes, led specifically by the trainees, students and juniors who submitted exceptional extracts.

Organised by the Royal Society for Medicine in association with the Association of British Clinical Diabetologists (ABCD) and the Society for Endocrinology.

Make your abstract submissions for clinical cases today via the links:

Thursday 30th April 2026, 17:00 - 18:15

Join us for our next webinar where we will be joined by Dr Debbie Wake and Dr Chris Sainsbury as they discuss the advances in AI over recent years, what the future looks like for diabetes and AI technology, and what its potential is when it comes to transforming diabetes care.

Joining Dr Petra Hanson this time on the ABCD Inspire Podcast is Dr Alistair Lumb, Consultant in Diabetes at Oxford University Hospital NHS Foundation Trust, Chair of the Diabetes Technology Network UK and a member of the EXTOD (Exercise in Type 1 Diabetes) faculty.

Alistair shares his extensive work in diabetes care, focusing on technology, exercise, and patient support, and shares insights into his career journey, the importance of mentorship, and the challenges faced in balancing clinical and non-clinical responsibilities.

The conference has been instigated and organised by ABCD. Sponsors, including pharmaceutical companies, have contributed funding towards this event in return for exhibition space. They have had no input into the agenda or the selection of speakers with the exception of any sponsored symposia which are clearly indicated.

A guideline from the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) Group

Jeffrey W. Stephens, Ketan Dhatariya, Andrew J. Beamish, Dimitri J. Pournaras, Alexander D. Miras, Nader Raafat, Georgia Noble-Bell, Rachel Cadwallader Buckland, Omar G. Mustafa

Diabet Med. 2026;43:e70281 (First published 16 March 2026) 
https://doi.org/10.1111/dme.70281 (PDF)

Following discussions with industry partners, we have been made aware of occasions where industry educators have been placed in unsafe situations. These include being asked to educate individuals who are high risk, without appropriate clinical support, without access to pump settings, and without a clearly documented clinical plan or follow-up pathway. This lack of structure creates risk for people with diabetes, both NHS and industry educators, and services.